India is currently facing its largest Chandipura virus outbreak in two decades, with at least 82 deaths reported among 245 cases of acute encephalitis syndrome (AES) between early June and August 15, 2024. This severe viral illness primarily affects children under 15 and can progress rapidly to brain inflammation and death. The World Health Organization reported a 33% case fatality rate during this recent surge.[who+5]
What is the Chandipura Virus?
The Chandipura virus (CHPV) belongs to the Rhabdoviridae family, which also includes the rabies virus. Scientists first identified the virus in 1965 in Chandipura village, Maharashtra, India, during an outbreak of feverish illness. CHPV is a zoonotic pathogen, meaning it originates in animal populations and can spread to humans. The virus causes acute encephalitis syndrome, a dangerous inflammation of the brain's active tissues. This condition predominantly impacts children, who often experience rapid and severe symptoms.[who+20]
How the Virus Spreads
The Chandipura virus primarily spreads through the bites of infected sandflies, particularly species from the Phlebotomus genus like Phlebotomus papatasi. Some research also suggests that mosquitoes, such as Aedes aegypti, and ticks can act as vectors. The virus thrives during India's monsoon season, when sandfly populations increase. Health experts note that sandflies often breed in damp areas, cracks in mud walls, and animal shelters, especially in rural and semi-urban settings. There is no documented evidence of direct human-to-human transmission of the Chandipura virus. Animal species like rodents, cattle, pigs, and dogs may also act as reservoirs, helping the virus persist in nature.[who+23]
Recognizing Chandipura Virus Symptoms
Chandipura virus infection typically begins with a sudden onset of symptoms that worsen quickly. Initial signs often mimic the flu, including high fever, severe headache, muscle pain, body aches, and frequent vomiting. As the disease progresses, patients can develop more severe neurological symptoms. These include seizures, convulsions, altered mental status, confusion, disorientation, unusual drowsiness, and eventually, a coma. In the most critical cases, the illness can lead to coma and death within 48 to 72 hours of symptoms appearing. Children under 15 are especially vulnerable due to their less developed immune systems and lower physiological reserves. Adults may experience milder or even subclinical infections that go unnoticed.[starhealth+34]
Outbreaks and Impact
The Chandipura virus is endemic in India, with outbreaks occurring regularly in the western, central, and southern regions. One significant historical outbreak occurred between June and August 2003, affecting 329 children and causing 183 deaths in Andhra Pradesh and Maharashtra. The current 2024 outbreak is considered the largest in the past two decades. Between early June and August 15, 2024, India's Ministry of Health and Family Welfare reported 245 cases of acute encephalitis syndrome (AES), with 82 fatalities, resulting in a 33% case fatality rate. Of these, 64 cases were laboratory-confirmed as Chandipura virus infections, including 61 from Gujarat and three from Rajasthan. Previous outbreaks have seen even higher fatality rates, ranging from 56% to 75%. Gujarat state, in particular, has seen a rise in CHPV outbreaks approximately every four to five years. As of August 5, 2026, Gujarat reported a fresh outbreak linked to Chandipura virus, with 22 suspected deaths and dozens of infections under investigation.[who+30]
Diagnosis, Treatment, and Prevention
Diagnosing Chandipura encephalitis can be challenging because its symptoms resemble other forms of viral encephalitis. The "gold standard" diagnostic method is Reverse Transcription Polymerase Chain Reaction (RT-PCR), which detects the virus's RNA in blood or cerebrospinal fluid (CSF). Other tests include Enzyme-Linked Immunosorbent Assay (ELISA) to detect antibodies and virus isolation from clinical samples. Brain scans like CT or MRI can help rule out other conditions but do not definitively diagnose Chandipura virus.[encephalitis+13]
There is currently no specific antiviral treatment or cure for Chandipura virus infection. Treatment focuses on supportive care to manage symptoms and prevent complications. This includes managing fever with medication, ensuring adequate hydration, providing oxygen therapy, and ventilation if needed, along with supportive care for neurological issues like seizures. Early medical assessment and timely referral of suspected AES cases to healthcare facilities can improve patient outcomes.[who+18]
Prevention is crucial in controlling the spread of Chandipura virus. Individuals should avoid insect bites by using protective clothing, mosquito nets, and insect repellents. Maintaining cleanliness in surroundings, eliminating stagnant water, and controlling insect breeding grounds are also essential. Public health responses during outbreaks include comprehensive insecticidal spraying, fumigation, and health awareness campaigns to inform the public and medical personnel about the virus, its symptoms, and preventive measures.[timesofindia+7]
Vaccine Development Efforts
Currently, no licensed vaccine is available for the Chandipura virus. However, extensive research is underway to develop effective vaccines. Scientists are exploring several candidate vaccines, including inactivated vaccines and recombinant glycoprotein-based vaccines. Studies in mice have shown promising results, with some candidate vaccines inducing seroconversion and protecting immunized animals from the live virus. A multi-epitope vaccine designed using immunoinformatics has also shown potential in in silico studies. These candidate vaccines are awaiting clinical trials before they can become widely available.[who+14]
The Chandipura virus remains a significant public health concern in India, particularly for children, underscoring the urgent need for continued research and robust public health interventions.
